Drug Type CAR-NK |
Synonyms- |
Target |
Action modulators |
Mechanism CLL-1 modulators(C-Type lectin domain family 12 member A modulators), IL-2 modulators(Interleukin-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | Germany | 08 Dec 2024 |